1. 3-Phenylpyruvate caused a dose-related stimulation of insulin release from rat pancreatic islets deprived of exogenous nutrient or incubated in the presence of 5.6 or 8.3 mM-D-glucose. 2. 3-Phenylpyruvate inhibited insulin release evoked by high concentrations of D-glucose (16.7 or 27.8mM) or 4-methyl-2-oxopentanoate (10.0mM). This inhibitory effect appeared to be attributable to impairment of 2-oxo-acid transport into the mitochondria, with resulting inhibition of D-glucose, pyruvate or 4-methyl-2-oxopentanoate oxidation. 3. 3-Phenylpyruvate failed to affect the oxidation of, and secretory response to, L-leucine, and did not augment insulin release evoked by a non-metabolized analogue of the latter amino acid. 4. L-Glutamine augmented 3-phenylpyruvate-induced insulin release. The release of insulin evoked by the combination of 3-phenylpyruvate and L-glutamine represented a sustained phenomenon, abolished in the absence of extracellular Ca2+ or the presence of menadione and potentiated by theophylline. 5. Whether in the presence or in the absence of L-glutamine, the secretory response to 3-phenylpyruvate coincided with an increase in 02 uptake, a decrease in K+ conductance, a stimulation of both Ca2+ inflow and 45Ca2+ net uptake and an increase in cyclic AMP content. 6. It is concluded that the release of insulin induced by 3-phenylpyruvate displays features classically encountered when the B-cell is stimulated by nutrient secretagogues, and is indeed attributable to an increase in nutrient catabolism.
1. 3-Phenylpyruvate caused a dose-related stimulation of insulin release from rat pancreatic islets deprived of exogenous nutrient or incubated in the presence of 5.6 or 8.3 mM-D-glucose. 2. 3-Phenylpyruvate inhibited insulin release evoked by high concentrations of D-glucose (16.7 or 27.8mM) or 4-methyl-2-oxopentanoate (10.0mM). This inhibitory effect appeared to be attributable to impairment of 2-oxo-acid transport into the mitochondria, with resulting inhibition of D-glucose, pyruvate or 4-methyl-2-oxopentanoate oxidation. 3. 3-Phenylpyruvate failed to affect the oxidation of, and secretory response to, L-leucine, and did not augment insulin release evoked by a non-metabolized analogue of the latter amino acid. 4. L-Glutamine augmented 3-phenylpyruvate-induced insulin release. The release of insulin evoked by the combination of 3-phenylpyruvate and L-glutamine represented a sustained phenomenon, abolished in the absence of extracellular Ca2+ or the presence of menadione and potentiated by theophylline. 5. Whether in the presence or in the absence of L-glutamine, the secretory response to 3-phenylpyruvate coincided with an increase in 02 uptake, a decrease in K+ conductance, a stimulation of both Ca2+ inflow and 45Ca2+ net uptake and an increase in cyclic AMP content. 6. It is concluded that the release of insulin induced by 3-phenylpyruvate displays features classically encountered when the B-cell is stimulated by nutrient secretagogues, and is indeed attributable to an increase in nutrient catabolism. Panten & Langer (1981) recently reported that 3-phenylpyruvate evokes insulin release from mouse pancreatic islets. Being unable to reveal a mechanism by which 3-phenylpyruvate could increase catabolic fluxes in islet cells, they proposed that a specific B-cell membrane receptor acts as mediator of the insulin-releasing capacity of 3-phenylpyruvate.
A simple metabolic explanation for the insulinreleasing capacity of 3-phenylpyruvate could, however, be visualized. Thus, 3-phenylpyruvate could be converted into phenylalanine by transamination with endogenous amino acids. The 2-oxo-acids derived from the endogenous amino acids would then be further utilized so that the release of insulin evoked by 3-phenylpyruvate would indeed coincide with an Abbreviation used: BCH, 2-endo-aminonorbornane-2-carboxylic -acid.
Vol. 210 increase in catabolic fluxes in islet cells. This hypothesis is supported by a number of experimental data in the present and the following paper . The results of the present study indicate that the secretory, ionic and oxidative responses of rat pancreatic islets to 3-phenylpyruvate are indeed compatible with the view that this 2-oxo acid stimulates islet metabolism. The nature of the metabolic events induced by 3-phenylpyruvate in islet cells are analysed in the following paper .
Materials and methods
All experiments were performed with islets isolated by collagenase digestion of pancreases removed from fed rats (Lacy & Kostianovsky, 1967) . The methods used to measure insulin release from incubated (Malaisse et al., 1970) (Herchuelz & Malaisse, 1978) islets, the fractional outflow rate of 41Ca2+ ) and 86Rb+ ) from prelabelled and perifused islets, the net uptake of 45Ca2+ by the islets (Malaisse-Lagae & Malaisse, 1971) , the cyclic AMP content of the islets and incubation media (Valverde et al., 1983) and the oxidation of exogenous nutrients have all been described previously in the cited publications.
For measuring°2 uptake, rat islets were cultured overnight in Parker's culture medium TC 199 containing 5.6mM-glucose and then placed in Cartesian divers in a Krebs-Ringer solution (Na+, 143.5mM; K+, 5.9mM; Mg2+, 1.2mM; Ca2+, 2.5mM; Cl-, 144.3 mM; S042, 1.2mM; P043-, 1.2mM) containing 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid (10mM; pH 7.4) and equilibrated against ambient air. The respiratory rate was recorded over two periods of 60 min each before and after addition of 3-phenylpyruvate from a side drop, the medium used throughout incubation being either deprived of exogenous nutrient or containing 10mM-L-glutamine (Hellerstrom, 1967) .
All results are expressed as means (± S.E.M.) together with the number of individual observations (given in parentheses). The statistical significance of differences between mean values was tested by using Student's t test.
Results

Secretory data
At a 10mM concentration, 3-phenylpyruvate significantly augmented insulin release from islets incubated for 90min in the absence of exogenous nutrient (Table 1 ). The secretory response to 3-phenylpyruvate was a rapid and reversible process (Fig. lc) . The increment in insulin output evoked by 3-phenylpyruvate was greater in the presence of D-glucose (5.6 or 8.3mM) or L-glutamine (2.0 or 10mM) than in the absence of exogenous nutrient (Tables 1 and 2 ; Fig. 1 ). In the presence of 5.6 mM-D-glucose, the secretory response to 3-phenylpyruvate was dose-related in the 1.0-10mM range (Fig. 2a) . In the presence of 1OmM-L-glutamine, which itself failed to stimulate insulin release (Table 2) , the stimulant action of 3-phenylpyruvate upon insulin release represented a sustained phenomenon whether judged from the dynamic pattern illustrated in Fig. 1 or the results of static experiments (Fig. 2b) . In the presence of L-glutamine (10mM), the secretory response to 3-phenylpyruvate was abolished in the absence of extracellular Ca2+ (Table 2 ) or in the presence of menadione (25 pM) and markedly augmented by theophylline (1.4mM), which itself fails to stimulate insulin release in the present system (Brisson et al., 1972) . In contrast with 3-phenylpyruvate, L-phenylalanine failed to stimulate insulin release in the absence of exogenous nutrient or in the presence of Lglutamine (Table 2 ). In good agreement with a prior observation (Sener et al., 1981) , L-phenylalanine augmented insulin output in the presence of 8.3 mM-D-glucose, but this stimulatory effect faded out at a higher concentration of the sugar (Table 1) .
1983 r 3-Phenylpyruvate-induced insulin release: ionic aspects Whereas 3-phenylpyruvate augmented insulin output in the presence of 5.6 or 8.3mM-D-glucose (Table 1) , it severely inhibited insulin release evoked by D-glucose in higher concentrations (16.7 and 27.8mM). 3-Phenylpyruvate also inhibited insulin release evoked by 10mM-4-methyl-2-oxopentanoate (Table 3 ). However, 3-phenylpyruvate failed to affect insulin release evoked by lOmM-L-leucine or 20mM-(±)-BCH (Table 3 ). In the absence of exogenous nutrient, the secretory response to 20mm-(±)-BCH was significantly higher than that evoked by lOmM-3-phenylpyruvate (P <0.001). Likewise, in the presence of L-glutamine (10mM), the release of insulin evoked by 20mM-(±)-BCH (312.8+2.8,uunits/90min per islet; n = 9) largely exceeded that evoked by l0mM-3-phenylpyruvate (152.3 + 7.4,-units/90min per islet; n = 55).
Ionic data
In static experiments, 3-phenylpyruvate significantly augmented 4SCa2+ net uptake in the absence of exogenous nutrient and, even more so, in the presence of L-glutamine (Table 4) . The relationship between 4SCa2+ net uptake and insulin release displayed the same pattern as that, repeatedly documented with other nutrient secretagogues and characterized by a threshold value for the stimulant action of Ca2+ upon insulin release (Malaisse-Lagae & Malaisse, 1971) , there being a tight correlation between the mean values for 4SCa2+ net uptake and insulin release respectively (r = 0.9772; n = 4; P < 0.05). 3-Phenylpyruvate augmented the cyclic AMP content of the islets and their surrounding incubation medium, as measured after 60 min incubation in the presence of 1.0mM-3-isobutyl-1-methylxanthine (Table 4 ). The cyclic AMP content was further increased (P<0.001) in the simultaneous presence of 3-phenylpyruvate and L-glutamine. Incidentally, L-glutamine alone augmented the cyclic AMP content above the basal value. This confirms a prior observation (Valverde et al., 1983) and is consistent with the knowledge that L-glutamine stimulates insulin release provided that the islets are incubated in the presence of a phosphodiesterase inhibitor .
In dynamic experiments, 3-phenylpyruvate caused an initial decrease and a later rise in the fractional outflow rate of 45Ca2+ from prelabelled islets perifused in the absence or in the presence of L-glutamine (Fig. la) . The mean value for 45Ca2+
fractional outflow rate before 3-phenylpyruvate administration was slightly but not significantly higher in the presence than in the absence of L-glutamine. The 3-phenylpyruvate-induced initial deceleration in 4TCa2+ fractional outflow rate was similar in both series of experiments, with a mean Table 3 . Effect of3-phenylpyruvate upon insulin release evoked by 4-methyl-2-oxopentanoate, L-leucine and (±)-BCH Pancreatic islets were incubated for 90min in the sole presence of 4-methyl-2-oxopentanoate, L-leucine or (±)-BCH or in the simultaneous presence of one of these nutrients and 3-phenylpyruvate (10mM). Results are means ± S.E.M. The statistical significance (P) of the 3-phenylpyruvate-induced changes in insulin output is indicated in each case. value of 842 + 139 per million/min2 (n = 8), but was more rapidly masked by the secondary rise in 45Ca2+ efflux in the presence of L-glutamine. The magnitude of such a secondary rise was also greater (P < 0.05) in the presence of L-glutamine (0.97 + 0.17%/min) than in its absence (0.44 + 0.02%/min).
3-Phenylpyruvate provoked a marked and rapidly reversible decrease in S6Rb+ outflow from prelabelled islets (Fig. lb) . The initial value (at 40-44 min) for 86Rb+ fractional outflow rate was significantly lower (P<0.001) in the presence of L-glutamine (3.84+0.06%/min) than in its absence (4.73 + 0.05%/min). The value reached within 6 min exposure to 3-phenylpyruvate was similar in both series of experiments. Thereafter, however, the 86Rb+ fractional outflow rate continued to slowly decrease in the absence of L-glutamine and slightly increased in the presence of the amino acid, so that the mean value reached between 64 and 68min of perifusion was higher (P <0.001) in the presence (1.78 + 0.03%/min) than in the absence of L-glutamine (1.46 + 0.03%/min).
Oxidative data
In the absence of exogenous nutrient, 3-phenylpyruvate (10mM) augmented 02 uptake by 23.2+5.6% (P<0.05) relative to the paired basal value (Table 4 ). In the presence of L-glutamine (10mM), the paired increment in 02 uptake was greater, averaging 69.3 + 7.5% (P< 0.001 
Discussion
The present results confirm that 3-phenylpyruvate stimulates insulin release, as recently reported by Panten & Langer (1981) . At variance with the view expressed by the latter authors, several findings in our study suggest that the insulin-releasing capacity of 3-phenylpyruvate coincides with, and may be secondary to, an increase in the catabolism of nutrients in the islet cells.
First, 3-phenylpyruvate increased 02 uptake by the islets. The increment in insulin release evoked by 3-phenylpyruvate, whether in the absence or in the presence of L-glutamine, was proportional to the increment in 02 uptake, with a mean ratio of 5 1.5,u-units/nl of 02 or 1.2,u-units/pmol of 02.
Secondly, the secretory response to 3-phenylpyruvate coincided with a decrease in 86Rb+ fractional outflow rate, a phenomenon that fails to occur in response to such non-nutrient secretagogues as L-arginine or the ionophore A23187 (Boschero & Malaisse, 1979; Henquin & Meissner, 1981) . 3-Phenylpyruvate caused an initial decrease and a later rise in 4SCa2+ efflux. This dual effect is observed in response to nutrient secretagogues such as D-glucose , L-leucine or 4-methyl-2-oxopentanoate (Hutton et al., 1980) , and is thought to reflect inhibition of Na+/Ca2+ counter-transport (initial fall) and facilitation of 40Ca2+ influx (late rise) respectively (Herchuelz et al., 1980a,b) . In good agreement with a recent report (Lenzen & Panten, 1981) , 3-phenylpyruvate stimulated 45Ca2+ net uptake. The 2-oxo-acid also provoked the accumulation of cyclic AMP in the islets and their surrounding incubation media. These findings suggest that, as is the case with other nutrient secretagogues, the functional response to 3-phenylpyruvate involves a decrease in K+ conductance, the subsequent gating of voltage-sensitive Ca2+ channels, the accumulation of Ca2+ in the cytosol of islet cells and the resulting activation via Ca2+-calmodulin of adenylate cyclase (Malaisse et al., 198 la) .
Thirdly, the relationship between changes in 86Rb+ fractional outflow rate and insulin release in the present series of experiments was in good agreement with present knowledge on the interdependency of these two variables in response to activation of the B-cell by nutrient secretagogues. L-Glutamine alone decreased s6Rb+ fractional outflow rate, but failed to stimulate insulin release. This finding, which confirms a prior observation , is identical with that observed at low concentrations of D-glucose (Carpinelli & Malaisse, 1981) and suggests that the cell membrane depolarization resulting from the decrease in K+ conductance must reach a critical level in order to cause the gating of Ca2+ channels and subsequent stimulation of insulin release. The value of 86Rb+ fractional outflow rate reached at 6min after exposure to 3-phenylpyruvate was not lower in the presence of L-glutamine than in its absence, despite the higher rate of insulin release recorded in the presence of the amino acid. This is also similar to what is seen whenever D-glucose is used in the range of concentrations in excess of the threshold value required for stimulation of insulin release (Carpinelli & Malaisse, 1981) . Moreover, the steady-state value for 86Rb+ outflow reached after prolonged exposure to 3-phenylpyruvate was somewhat higher in the presence than in the absence of L-glutamine. This is again reminiscent of what is observed in response to D-glucose, in which case a secondary activation of a Ca2+-sensitive modality of K+ extrusion is held responsible for the higher value of 86Rb+ fractional outflow observed at high than at intermediate glucose concentrations (Lebrun et al., 1982) .
Fourthly, the fact that 3-phenylpyruvate, unlike other nutrient secretagogues, did not merely shift to the left the sigmoidal curve relating insulin output to the ambient glucose concentration, does not detract but, on the contrary, reinforces the view that the secretory response to 3-phenylpyruvate depends closely on the regulation of oxidative events in the islet cells. Indeed, the inhibitory effect of 3-phenylpyruvate upon insulin release evoked by high concentrations of D-glucose or by 4-methyl-2-oxopentanoate coincided with a decrease in glucose or 4-methyl-2-oxopentanoate oxidation. Since 3-phenylpyruvate also inhibited pyruvate oxidation, it seems most likely that 3-phenylpyruvate interferes with the transport of 2-oxo-acids (e.g., pyruvate derived from either an exogenous source or endogenous glucose metabolism) into the mitochondria (Halestrap et al., 1974) . This interpretation is consistent with the observation that 3-phenylpyruvate failed to affect L-leucine oxidation, since the oxidation of this amino acid depends on the mitochondrial rather than extramitochondrial conversion of L-leucine into 4-methyl-2-oxopentanoate (Malaisse et al., 1982a ). Our interpretation is also supported by the existence of a significant correlation between the magnitude of the 3-phenylpyruvate-induced decrease in 14C02 output and the control value for such an output, suggesting that the inhibitory effect of 3-phenylpyruvate is most evident when the capacity of the mitochondrial transport system is close to saturation.
Fifthly, L-glutamine markedly enhanced the oxidative, ionic and secretory response to 3-phenylpyruvate. In previous studies, we have demonstrated that the capacity of L-glutamine to augment insulin release evoked by either activators of glutamate dehydrogenase (e.g., leucine of BCH) or 2-oxo-acids acting as 'partners' in the transamination of L-glutamate (derived from exogenous Lglutamine) to 2-oxoglutarate (e.g., 4-methyl-2-oxopentanoate) can be readily accounted for by the .changes in oxidative fluxes evoked by L-glutamine in the islet cells (Malaisse et al., 198 lb, 1982b; Malaisse-Lagae et al., 1982) . The capacity of L-glutamine to augment 3-phenylpyruvate-stimulated insulin release is likely therefore to be attributable to a comparable process. Since 3-phenyl-1983 pyruvate does not activate glutamate dehydrogenase (Panten & Langer, 1981) , interference by 3-phenylpyruvate of the transamination of L-glutamate would appear to be the most likely explanation for the synergistic effect of 3-phenylpyruvate and L-glutamine on insulin release. This interpretation is further supported by the finding that 3-phenylpyruvate failed to augment insulin release evoked by either L-leucine or its non-metabolized analogue BCH. These two amino acids are known to increase considerably the oxidative deamination and further catabolism of endogenous amino acids in the islet cells. If 3-phenylpyruvate were to act in a comparable but not identical manner, namely by facilitating the transamination and further catabolism of endogenous amino acids, it would seem reasonable to speculate that 3-phenylpyruvate would not augment the secretory response to L-leucine (or BCH), the availability of endogenous amino acids eventually representing a rate-limiting factor. The latter view is again supported by the knowledge that exogenous L-glutamine augments 3-phenylpyruvateinduced insulin release.
Lastly, the secretory response to the combination of 3-phenylpyruvate and L-glutamine was abolished by menadione, which inhibits nutrient-stimulated functional events in the islet cells by lowering their content in reduced nicotinamide nucleotides . This finding again suggests that the response to 3-phenylpyruvate includes an increase in the catabolism of nutrients in the islet cells, with induction of a more reduced redox state.
The mechanism by which 3-phenylpyruvate indeed stimulates catabolic events in the islet cells is considered in the following paper .
